Common Contracts
1 similar Clinical Collaboration Agreement contracts
Telix Pharmaceuticals and Radboud University Medical Centre Conclude Clinical Collaboration AgreementClinical Collaboration Agreement • March 15th, 2018
Melbourne (Australia) and Nijmegen (Netherlands) – 15 February 2018. Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularly-targeted radiation” (MTR), has today announced a clinical collaboration with Radboud University Medical Center (“Radboudumc”).
